# ðŸš€ Beta Launch Checklist - Nexus Biomedical Intelligence

**Last Updated:** December 1, 2025  
**Status:** Pre-Launch Testing Phase  
**Target:** Physician Demo Ready

---

## âœ… COMPLETED CRITICAL FIXES

### Authentication & Database
- [x] Fixed login/signup APIs (JSON responses, timeout handling)
- [x] Fixed database connection timeouts (10s connection, 20s query)
- [x] Increased Vercel function timeout (10s â†’ 30s)
- [x] Fixed trial activation database schema (added platform, trial_start, selected_plan columns)
- [x] Made Stripe fields nullable for free trials

### Platform Functionality
- [x] Fixed gender-specific symptoms in EndoGuard (male vs female reproductive symptoms)
- [x] Fixed EndoGuard assessment API (serverless function)
- [x] Fixed RxGuard trial activation (automatic on platform access)
- [x] Fixed Dashboard blank screen issue
- [x] Added plan selection before trial activation

### SMS Notification System
- [x] Database migrations completed (notification_preferences, sms_campaigns, sms_campaign_sends, sms_health_tips)
- [x] 60 evidence-based health tips with scientific citations loaded
- [x] 5 SMS campaigns configured
- [x] Twilio integration tested and working

### UI/UX Improvements
- [x] Fixed header overlap (language toggle + login button)
- [x] Added "Back to Home" buttons to all platforms
- [x] Fixed EndoGuard color scheme (magenta #D946EF)
- [x] Enhanced Dashboard with premium styling
- [x] Added trial expiration banners

---

## ðŸ”´ CRITICAL TASKS FOR PHYSICIAN DEMO

### Testing Required (HIGH PRIORITY)
- [ ] **Test EndoGuard gender-specific symptoms on production**
  - [ ] Create test account as female user
  - [ ] Verify female symptoms display (menstrual cycles, PMS, vaginal dryness, breast tenderness)
  - [ ] Create test account as male user
  - [ ] Verify male symptoms display (erectile dysfunction, low testosterone, gynecomastia, testicular atrophy)

- [ ] **Test subscription tiers**
  - [ ] RxGuard: $39/month with 14-day trial
  - [ ] EndoGuard Premium: $49/month with 14-day trial
  - [ ] EndoGuard Premium Plus: $97/month with 14-day trial
  - [ ] Verify Stripe checkout works
  - [ ] Verify trial-to-paid conversion

- [ ] **Test complete user journey**
  - [ ] Signup â†’ Dashboard â†’ Start Free Trial â†’ Platform Access
  - [ ] Complete EndoGuard assessment â†’ View results
  - [ ] RxGuard medication search â†’ Interaction analysis
  - [ ] PDF export functionality

### SMS System Testing
- [ ] Test SMS preferences UI at /settings/sms
- [ ] Test assessment completion SMS
- [ ] Test high-risk alert SMS (score â‰¥70)
- [ ] Verify Twilio account is upgraded (currently trial mode - Error 30044)

### Documentation for Demo
- [ ] Create physician demo script
- [ ] Prepare sample patient scenarios (male and female)
- [ ] Document key features to highlight
- [ ] Prepare FAQ responses for physician questions

---

## ðŸŸ¡ IMPORTANT BUT NOT BLOCKING

### SMS Campaigns (Can Launch After Demo)
- [ ] Test weekly health tips campaign (Mondays 11 AM)
- [ ] Test monthly assessment reminders (1st of month)
- [ ] Test 7/14/30-day engagement reminders
- [ ] Monitor SMS delivery rates

### Admin Tools
- [ ] Test admin analytics dashboard
- [ ] Verify SMS campaign management
- [ ] Check referral program functionality

### Legal & Compliance
- [ ] Review Privacy Policy and Terms of Service
- [ ] Verify HIPAA disclaimers are accurate
- [ ] Ensure medical disclaimers are prominent

---

## ðŸŸ¢ FUTURE ENHANCEMENTS (Post-Beta)

### Platform Expansion
- [ ] Complete ElderWatch platform
- [ ] Complete PediCalc Pro platform
- [ ] Complete ClinicalIQ platform
- [ ] Complete ReguReady platform
- [ ] Complete SkinScan Pro platform

### Advanced Features
- [ ] A/B testing for conversion optimization
- [ ] Predictive churn prevention
- [ ] Advanced analytics dashboard
- [ ] Multi-language support (Spanish)
- [ ] Provider dashboard for NP/OBGYN partners

### Marketing & Growth
- [ ] Email drip campaigns
- [ ] Referral rewards program
- [ ] Social media integration
- [ ] Content marketing strategy
- [ ] SEO optimization

---

## ðŸ“Š DEMO READINESS CHECKLIST

### Before Physician Demo
- [ ] Test all features on production (not just dev)
- [ ] Verify gender-specific symptoms work correctly
- [ ] Ensure no console errors or warnings
- [ ] Test on mobile device (physician may use phone)
- [ ] Prepare backup demo account (in case of issues)
- [ ] Have sample patient data ready
- [ ] Know how to handle questions about:
  - HIPAA compliance (pseudonymous design)
  - FDA approval (clinical decision support, not medical device)
  - Scientific validation (algorithm documentation)
  - Pricing and business model

### During Demo
- [ ] Show EndoGuard assessment (both male and female scenarios)
- [ ] Show RxGuard drug interaction checker
- [ ] Highlight AI-powered analysis
- [ ] Demonstrate PDF export
- [ ] Show test recommendations with citations
- [ ] Emphasize evidence-based approach
- [ ] Address credibility concerns proactively

### After Demo
- [ ] Collect feedback
- [ ] Note any bugs or issues
- [ ] Document feature requests
- [ ] Follow up on partnership opportunities

---

## ðŸŽ¯ SUCCESS CRITERIA

**Physician Demo is successful if:**
1. âœ… Gender-specific symptoms display correctly (no embarrassing errors)
2. âœ… Assessment completes without errors
3. âœ… Results are medically accurate and credible
4. âœ… Platform feels professional and polished
5. âœ… Physician expresses interest in partnership or referral

**Beta Launch is successful if:**
1. 10+ beta users complete assessments
2. No critical bugs reported
3. Positive feedback on UX and accuracy
4. At least 1 paid subscription conversion
5. SMS system working reliably

---

## ðŸ“ž SUPPORT & TROUBLESHOOTING

**If something breaks during demo:**
- Have backup demo account ready
- Know how to quickly rollback to previous checkpoint
- Have Vercel logs open in another tab
- Be prepared to explain "beta status" if needed

**Key Documentation:**
- ENDOGUARD_ALGORITHM_DOCUMENTATION.md
- SMS_IMPLEMENTATION_GUIDE.md
- PRODUCTION_TESTING_CHECKLIST.md
- HIPAA_SAFETY_FAQ.md

---

**Next Immediate Action:** Test gender-specific symptoms on production after publishing latest checkpoint
